» Articles » PMID: 1333056

Molecular Cloning and Expression of a Pituitary-specific Receptor for Growth Hormone-releasing Hormone

Overview
Journal Mol Endocrinol
Date 1992 Oct 1
PMID 1333056
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

A novel cDNA was isolated from rat pituitary mRNA using the polymerase chain reaction to amplify sequences encoding G protein-coupled receptors. The human homolog of this cDNA was isolated and expressed in human kidney 293 cells, and membrane fractions from these cells were found to bind human GH-releasing hormone (GHRH) with high affinity and specificity. GHRH also stimulates intracellular cAMP production in these transfected cells. The encoded receptor protein contains seven potential membrane-spanning domains, a hallmark of G protein-coupled receptors, and is homologous to previously identified receptors for secretin and vasoactive intestinal peptide, ligands that are related to GHRH. The rat GHRH receptor mRNA is expressed predominantly, if not exclusively, in the anterior pituitary gland, the major target for GHRH action. These results define a mechanism for cellular signaling by GHRH and provide the opportunity to examine the role of the GHRH receptor in growth abnormalities that involve the GH axis.

Citing Articles

Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.

Poelman R, Le May M, Schele E, Stoltenborg I, Dickson S Endocrinology. 2025; 166(3).

PMID: 39813130 PMC: 11795113. DOI: 10.1210/endocr/bqae166.


Growth hormone-releasing hormone and its analogues in health and disease.

Granata R, Leone S, Zhang X, Gesmundo I, Steenblock C, Cai R Nat Rev Endocrinol. 2024; 21(3):180-195.

PMID: 39537825 DOI: 10.1038/s41574-024-01052-1.


Alleviation of LPS-induced Endothelial Injury due to GHRH Antagonist Treatment.

Fakir S, Kubra K, Akhter M, Uddin M, Barabutis N Int J Pept Res Ther. 2024; 30(6).

PMID: 39465062 PMC: 11500629. DOI: 10.1007/s10989-024-10653-3.


Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in a Cohort of Hungarian Pediatric Patients with Hematological and Oncological Disorders: A Pilot Study.

Juhasz E, Szabo Z, Schally A, Kiraly J, Fodor P, Konya G Int J Mol Sci. 2024; 25(16).

PMID: 39201517 PMC: 11354965. DOI: 10.3390/ijms25168831.


Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease.

Sangwung P, Ho J, Siddall T, Lin J, Tomas A, Jones B Am J Physiol Endocrinol Metab. 2024; 327(5):E600-E615.

PMID: 38984948 PMC: 11559640. DOI: 10.1152/ajpendo.00371.2023.